🇺🇸 FDA
Patent

US 7902235

Compounds for nonsense suppression, and methods for their use

granted A61PA61P1/16A61P11/00

Quick answer

US patent 7902235 (Compounds for nonsense suppression, and methods for their use) held by PTC THERAPEUTICS, INC. expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P1/16, A61P11/00, A61P13/12, A61P19/00